WHO guidelines for the treatment of chlamydia trachomatis

RATIONALE FOR THE GUIDELINES: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated...

Full description

Corporate Author: World Health Organization
Format: eBook
Language:English
Published: Geneva, Switzerland World Health Organization [2016], 2016
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02264nam a2200265 u 4500
001 EB001840162
003 EBX01000000000000001004151
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
020 |a 9789241549714 
245 0 0 |a WHO guidelines for the treatment of chlamydia trachomatis  |h Elektronische Ressource  |c World Health Organization 
260 |a Geneva, Switzerland  |b World Health Organization  |c [2016], 2016 
300 |a 1 PDF file (iv, 47 pages) 
505 0 |a Includes bibliographical references 
653 |a Chlamydia Infections / therapy 
653 |a Chlamydia trachomatis / pathogenicity 
653 |a Sexually Transmitted Diseases / therapy 
710 2 |a World Health Organization 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 |u https://www.ncbi.nlm.nih.gov/books/NBK379707  |3 Volltext 
082 0 |a 610 
520 |a RATIONALE FOR THE GUIDELINES: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated treatment recommendations for common infections caused by C. trachomatis based on the most recent evidence; they form one of several modules of guidelines for specific STIs. Other modules will focus on treatments for Neisseria gonorrhoeae (gonorrhoea), herpes simplex virus type 2 (HSV-2; genital herpes) and Treponema pallidum (syphilis). In addition, future work will provide guidance for syphilis screening and treatment of pregnant women, STI syndromic approach, clinical management, STI prevention, and treatments of other STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols, adapting this guidance to the local epidemiological situation and antimicrobial susceptibility data. OBJECTIVES: The objectives of these guidelines are: 1. to provide evidence-based guidance on treatment of infection with C. trachomatis; and 2. to support countries to update their national guidelines for treatment of chlamydial infection